The clinical-stage biotech could see its shares plummet should there be any clinical setback.
Morning Overview on MSN
China’s EV crush at home is pushing foreign brands out
China’s electric vehicle boom has flipped the balance of power in the world’s largest auto market, turning foreign brands ...
"Healthy economic and revenue growth, continued profit strength among the largest US stocks, and an emerging productivity ...
Guardians star third baseman Jose Ramirez claims he is open to staying in Cleveland for the rest of his career.
Oklo is designing and developing small nuclear reactors. After a strong run in 2025, the company's stock looks expensive.
Markets in the Northeast are expected to see the biggest home price increases this year, according to experts.
Bitcoin and XRP prices held firm ahead of the U.S. Supreme Court’s pending decision on trade tariffs set for January 14. The ...
The historic estate, once home to Gill St. Bernard, has been on and off the market since 2014 with multiple price reductions.
NuScale faces long timelines, restrictive ENTRA1 deals, 2030 EBITDA priced in, and Fluor stake risks, limiting near-term ...
Although Wall Street has been flush with catalysts, headwinds are mounting. When 2026 comes to a close, it's my prediction ...
Mutuum Finance (MUTM) has provided a new update on its technical roadmap as development for its decentralized lending ...
Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results